Huiren Pharmaceutical

Huiren Pharmaceutical was established in 2001 and is a pharmaceutical enterprise invested and founded by Huiren Group, integrating pharmaceutical wholesale, retail, and marketing services. It currently has more than 3,000 employees and owns several subsidiaries including Huiren Pharmaceutical Trading, Huirentang Chain Pharmacies, and Shanghai Huiren. It has invested over 100 million yuan to establish multiple branches in Ganzhou, Yichun, Shangrao, Ji'an, Fuzhou, Xinfeng, Ningdu, Huichang, and Dongxiang. Its main business covers wholesale and retail, medical devices, vaccine distribution and storage, etc., with a sales network covering the entire province and more than 20,000 customers. It is among the top 50 pharmaceutical commercial enterprises nationwide, with sales approaching 10 billion yuan in 2021, and plans to list on the main board in 2022.
The position we are currently recruiting for belongs to Taijili Biopharmaceutical Technology, a newly established subsidiary under the pharmaceutical division. Its business scope includes drug import and export, drug operation, drug production, drug technical services, technology transfer, etc. It is a wholly-owned subsidiary of Huiren Pharmaceutical, mainly involved in small-volume injections, oral solid preparations (tablets, hard capsules, granules, etc.) and other dosage forms. At present, 106 mu of land has been finalized for preparation production, with equipment planned to enter the factory this year and put into use in 2024.